Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.28
5.47
7.81
142.78%
Share Warrants & Outstandings
Total Reserve
204.71
259.33
-54.62
-21.06%
Shareholder's Funds
239.95
278.71
-38.76
-13.91%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
56.31
-56.31
-100.00%
Secured Loans
0.00
56.31
-56.31
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.07
6.55
-3.48
-53.13%
Other Long Term Liabilities
8.30
0.00
8.30
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.04
4.26
-3.22
-75.59%
Total Non-Current Liabilities
12.41
67.11
-54.70
-81.51%
Current Liabilities
Trade Payables
9.73
87.47
-77.74
-88.88%
Other Current Liabilities
15.16
43.13
-27.97
-64.85%
Short Term Borrowings
0.00
165.72
-165.72
-100.00%
Short Term Provisions
1.01
0.00
1.01
0.00%
Total Current Liabilities
25.90
296.31
-270.41
-91.26%
Total Liabilities
278.26
642.14
-363.88
-56.67%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.47
0.00
93.47
0.00%
Less: Accumulated Depreciation
7.25
0.00
7.25
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
86.23
118.23
-32.00
-27.07%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
2.02
-2.02
-100.00%
Long Term Loans & Advances
1.33
12.43
-11.10
-89.30%
Other Non Current Assets
21.29
11.21
10.08
89.92%
Total Non-Current Assets
117.07
143.89
-26.82
-18.64%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
15.20
269.80
-254.60
-94.37%
Sundry Debtors
13.18
92.69
-79.51
-85.78%
Cash and Bank
128.73
64.95
63.78
98.20%
Other Current Assets
1.66
7.08
-5.42
-76.55%
Short Term Loans and Advances
2.42
63.72
-61.30
-96.20%
Total Current Assets
161.19
498.24
-337.05
-67.65%
Net Current Assets (Including Current Investments)
135.29
201.93
-66.64
-33.00%
Total Current Assets Excluding Current Investments
161.19
498.24
-337.05
-67.65%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
278.26
642.14
-363.88
-56.67%
Contingent Liabilities
16.17
0.00
16.17
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
36.08
0.00
36.08
0.00%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 86.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Current Assets
Current Assets 161.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024
